Whitepapers/App Notes/Posters

Case study: GC-MS for cGMP nitrosamine testing

Posted: 17 December 2021 | | No comments yet

What pharmaceutical QA/QC laboratories need to know to overcome the challenges of nitrosamine impurities in drugs for cGMP testing.

The low levels at which the nitrosamine impurities could be present in pharmaceutical products pose challenges for analytical laboratories. The limits imposed by regulations are strict and could potentially be lowered to ensure patients safety. Single quadrupole ISQ 7000 GC-MS and triple quadrupole TSQ 9000 GC-MS/MS systems are compliance-ready with FDA regulation, meeting, often exceeding the method requirements and providing the sensitivity, selectivity and precision needed for reliable quantitative analysis of these impurities.












    To read this case study in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of Thermo Fisher Scientific

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.